Publications (70) Ángel Fernando Panizo Santos publications

2020

  1. Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression

    British Journal of Haematology, Vol. 189, Núm. 6, pp. 1064-1073

2017

  1. First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study

    European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43

  2. Proliferación linfoide atípica intravascular de linfocitos T-CD30+ sobre granuloma piogénico (hemangioma capilar lobular)

    Revista Espanola de Patologia, Vol. 50, Núm. 3, pp. 188-191

2016

  1. Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity

    Immunologic Research, Vol. 64, Núm. 2, pp. 548-557

2014

  1. Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications

    Clinical Genitourinary Cancer, Vol. 12, Núm. 2, pp. 87-93

2013

  1. Conjunctival juvenile xanthogranuloma in a preschool child

    Ocular Immunology and Inflammation

  2. Hepatoblastoma en el adulto

    Revista Espanola de Enfermedades Digestivas, Vol. 105, Núm. 4, pp. 229-231

2011

  1. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome

    BJU International, Vol. 108, Núm. 2 B

  2. Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma

    BJU International, Vol. 107, Núm. 11, pp. 1833-1838

  3. Prostatic leiomyoma. Case report

    Archivos Espanoles de Urologia, Vol. 64, Núm. 7, pp. 631-635

2010

  1. Id-1 expression and prognosis in cancer: Do antibodies matter?

    Clinical and Translational Oncology

2009

  1. Clasificación y diagnóstico anatomopatológico de los tumores hepáticos benignos

    Gastroenterologia y Hepatologia Continuada, Vol. 8, Núm. 1, pp. 1-8

  2. Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

    British Journal of Cancer, Vol. 101, Núm. 11, pp. 1876-1883

  3. Large cell carcinoma of the lung: An endangered species?

    Applied Immunohistochemistry and Molecular Morphology, Vol. 17, Núm. 5, pp. 383-392

2008

  1. Primary mixed squamous carcinoma and osteosarcoma (carcinosarcomas) of the lung have a CGH mapping similar to primitive squamous carcinomas and osteosarcomas

    Diagnostic Molecular Pathology, Vol. 17, Núm. 3, pp. 151-158

2007

  1. Fourth branchial cyst within the thyrohyoid membrane: a difficult differential diagnosis with mixed laryngocele

    Revista de medicina de la Universidad de Navarra, Vol. 51, Núm. 4, pp. 34-37

  2. Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile

    Annals of Diagnostic Pathology, Vol. 11, Núm. 4, pp. 241-251

2006

  1. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction

    Cardiovascular Research, Vol. 71, Núm. 4, pp. 744-753

  2. Proteomic identification of new biomarkers and application in thyroid cytology

    Acta Cytologica, Vol. 50, Núm. 5, pp. 518-528

  3. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 66, Núm. 3, pp. 792-800